Mirador Therapeutics Company
Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases using an integrated discovery and development platform. The company’s Mirador360 engine combines human genetics, multi-modal data, and analytical tools to identify therapeutic targets, support patient stratification, and inform drug design. Its offerings include research programs and pipeline assets aimed at conditions such as chronic inflammation and tissue fibrosis. Mirador Therapeutics works with scientific and medical stakeholders to advance targeted therapeutic candidates through preclinical and clinical development.
Funding Status:
Private
Employee Number:
11-50
Last Funding Date:
2026-01-12
Headquarters:
San Diego,California,United States,North America
Founded Date:
2024-01-01
Total Funding:
730000000
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
730000000
Last Funding Total Usd:
250000000
Last Funding Total Currency:
USD
Last Funding Total Value:
250000000
Founders:
Mark McKenna